文献速递肝胆胰外科胃肠外科

结直肠癌肝转移肝切除术后切缘复发与R1切除无关且不影响生存

Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
PubMed 文献 · Surgery · 2020-12-30

该多中心回顾性研究纳入2012至2017年间345例结直肠癌肝转移肝切除术患者,其中R1切除63例(18%),中位随访34个月后复发154例(45%)。肝局部复发在R1与R0间无差异(P=.555),肝局部复发与总生存无关(P=.436),而R1状态显著损害总生存(P=.025)。

要点

  • R1切除不增加肝局部复发风险(P=.555)。
  • 肝局部复发不影响总生存(P=.436),R1状态显著损害总生存(P=.025)。
  • 仅肝内复发患者若可行局部治疗(切除或消融),3年总生存85% vs 39%(P<.0001)。

核心结论

  • 结直肠癌肝转移肝切除术后肝局部复发独立于R1切缘状态。
  • 切缘肝局部复发与任何肝内或肝外复发相比不降低总生存。
  • R1状态可能是晚期疾病的替代标志,不影响复发部位及肿瘤学结局。

研究设计与样本

  • 两中心(瑞士伯尔尼和德国柏林)2012至2017年连续345例结直肠癌肝转移根治性肝切除术患者的回顾性队列研究。
  • 肝切除术后横断面影像由两中心放射科医师审阅,区分切缘肝局部复发与肝内其他部位复发。
  • 分析手术切缘状态与肿瘤复发部位的关联,并确定对总生存的影响。

主要发现

  • 345例患者中R1切除63例(18%)。
  • 中位随访34个月,肿瘤复发154例(45%)。
  • R1与R0切除后肝局部复发无差异(P=.555)。
  • 肝局部复发与总生存无关(P=.436),R1状态显著损害总生存(P=.025)。
  • 仅肝内复发患者中,可行局部治疗(切除或消融)者3年总生存85% vs 仅化疗或最佳支持治疗39%(P<.0001)。

临床怎么用

  • 肝切除术后肝局部复发不应单独归因于R1切缘,需结合全身疾病评估。
  • R1状态提示晚期疾病,应关注整体肿瘤学治疗而非仅切缘处理。
  • 仅肝内复发且可行局部治疗(切除或消融)者生存获益显著。
  • 该发现可能支持对临界可切除结直肠癌肝转移扩大手术指征的决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Resection margin status has traditionally been associated with tumor recurrence and oncological outcome following liver resection for colorectal liver metastases. Previous studies, however, did not address the impact of resection margin on the site of tumor recurrence and did not differentiate between true local recurrence at the resection margin and recurrence elsewhere in the liver. This study aimed to determine whether positive resection margins determine local recurrence and whether recurrence at the surgical margin influences long-term survival. METHODS: Clinicopathological data and oncological outcomes of patients who underwent curative resection for colorectal liver metastases between 2012 and 2017 at 2 major hepatobiliary centers (Bern, Switzerland, and Berlin, Germany) were assessed. Cross-sectional imaging following hepatectomy was reviewed by radiologists in both centers to distinguish between recurrence at the resection margin, defined as hepatic local recurrence, and intrahepatic recurrence elsewhere. The association between surgical margin status and location of tumor recurrence was evaluated, and the impact on overall survival was determined. RESULTS: During the study period, 345 consecutive patients underwent hepatectomy for colorectal liver metastases. Histologic surgical margins were positive for tumor cells (R1) in 63 patients (18%). After a median follow-up time of 34 months, tumor recurrence was identified in 154 patients (45%). Hepatic local recurrence was not detected more frequently after R1 than after R0 resection (P = .555). Hepatic local recurrence was not associated with worse overall survival (P = .436), while R1 status significantly impaired overall survival (P = .025). Additionally, overall survival was equivalent between patients with hepatic local recurrence and patients with any intrahepatic and/or extrahepatic recurrence. In patients with intrahepatic recurrence only, oncological outcomes improved if local hepatic therapy was possible (resection or ablation) in comparison to patients treated only with chemotherapy or best supportive care (3-year overall survival: 85% vs 39%; P < .0001). CONCLUSION: The incidence of hepatic local recurrence after hepatectomy for colorectal liver metastases is independent of R1 resection margin status. Additionally, hepatic local recurrence at the resection margin is not associated with worse overall survival compared with any other intra- or extrahepatic recurrence. Therefore, R1 status at hepatectomy seems to be a surrogate factor for advanced disease without influencing location of recurrence and thereby oncological outcome. This finding may support decision-making when extending the indication for surgery in borderline resectable colorectal liver metastases.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Andreou A, Knitter S, Schmelzle M, et al. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival. Surgery. 2020. PMID: 33386128. doi:10.1016/j.surg.2020.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。